THE B 1 6 melanoma has been extensively used for studies in experimental chemotherapy (Griswold, 1972 (Griswold, , 1975 and has been included in the National Cancer Institute screening programme for chemotherapeutic agents. Our interest has been in the development and application of assays for clonogenic cells within experimental tumours, and results on the Lewis lung tumour have already been described (Steel and Adams, 1975) . The B16 melanoma has proved to be a highly transplantable tumour that is easily assayed for clonogenic cell survival. The present paper describes its performance in 3 different assays and the results that have been obtained in studying its response to single doses of cyclophosphamide (CY) . MATERIALS Fig. 1 . It was obtained on 2 groups of 10 tumours whose superficial dimensions were transformed into estimated tumour weights using a calibration-curve technique (Steel and Adams, 1975 (Hewitt, 1953 Three experiments using intracerebral implantation showed that the TD50 without lethally irradiated cells was probably lower than for either of the other 2 sites, but that when lethally irradiated cells were added, the results were no better than for s.c. implantation.
The effect of varying the number of lethally irradiated cells was investigated in the s.c. site (Fig. 3) . As the number was reduced from 106 to 105, the TD50 increased by more than a factor of 10; increasing the lethally irradiated cells to 5 x 106 may have produced a slight decrease in the TD50.
Two experiments were performed to test the antigenicity of the B16 melanoma repeated at the same intervals and the challenge was again one week later. The TD50 for hind leg implantation was then 0-9 cells (confidence limits 0-5-1.6) with a simultaneous control in unimmunized mice of 1 -cells (confidence limits 0 6-1 9).
Lung colony assay
The technique of lung colony assay was as has been described for the Lewis lung tumour (Hill and Stanley, 1975; Steel and Adams, 1975) . Viable cells were injected i.v. together with 106 plastic microspheres and 106 lethally irradiated tumour cells. The mice were killed 21-25 days later, and lung colonies were counted after fixation of the lungs in Bouin's fixative. With untreated tumour cells, there was a good linear relationship between the number of viable cells injected and the colonv count (Fig. 4) . It was noted that the B16 lung colonies varied in colour from pale grey to dark black, as described by Hill and Stanley (1975 
In vitro assay
The third assav that has been used for the B16 melanoma is the in vitro assay described by Courtenay (1976) and by Stephens, Peacock and Steel (1977) . This was a double-layer soft-agar technique in which rat red blood cells provided an essential growth factor and the incubations were carried out in 50 02, 50 CO2 and 9000 N2. The colonies were counted at 14-18 days and the usual plating efficiency was 30-5000.
Response of the B16 melanoma to cyclophosphamide
The methods described here have been employed in studies of the response of the B 16 melanoma to a number of chemotherapeutic agents, the results of which will be the subject of a subsequent publi- The duration of cytotoxic action of a single i.p. injection of CY was explored by implanting B16 cells intramuscularly at various intervals after 300 mg/kg of the drug. Cell survival studies on previously implanted tumours (see below) lead us to expect that the effect of this dose would be to increase the TD50 from 1-2 cells to about 100 cells. When cells were implanted I h after drug injection, the TD50 was 7 2 (confidence limits 4.2-12); by 2 h the TD50 had returned to the control level, thus the blood level of active metabolite had fallen below the toxic limit.
The dose-response curve for cell survival following the treatment of s.c. tumours with CY is shown in Fig. 5 . The drug was given i.p., and the mice were killed 18 h later. All three assays were used in this study and although the range of values determined by the in vitro assay tended to be greater than for the in vivo assays there was good agreement between them. The dose-response curve is exponential, reach- ing 4 X 10-3 at the maximum tolerated dose of 300 mg/kg.
DISCUSSION
The main purpose of this paper is to indicate that in our hands the B 1 6 melanoma has been a highly transplantable tumour that can easily be assayed for clonogenic cell survival. XVhen proper use was made of the Revesz effect (Revesz, 1958) and when the i.m. site was used, the number of cells required for 50%o tumour takes was approximately 1-2, not far short of the ultimate theoretical value of 0-69 cells (i.e. In 2). The mechanism of the Revesz effect is not fully understood, but Peters and Hewitt (1974) have suggested that the main effect of lethally irradiated tumour cells may be to induce a clotting mechanism that prevents the implanted cells from escaping from the implantation site and thus becoming more vulnerable to host defence mechanisms. Throughout the work reported here, and in other experi-ments on the BI 6 melanoma, the relation between tumour take probability and the number of viable cells injected (Fig. 2 Fig. 4 indicate a lung cloning efficiency of 1-3 x 10-3 (i.e. one colonv per 700 cells injected), in good agreemeint with the results of Hill and Stanley (1975 (Courtenay 1976; . The method is also able to measure surviving fractions down to about 10-3 and it has the advantages of speed and economy over the 2 in vivo techniques.
Nevertheless, the greater sensitivity of the end-point dilutioni assav is an importaut, factor when low levels of survival are to be explored.
A single straight line has been drawn through the survival data in Fig. 5 (Shipley et al., 1975; Steel and Adams, 1975) . The sensitivity of the B] 6 melanoma to CY is, however, lower by a factor of 3 than the Lewis lung tumour. With each of these tumours, following a variety of cytotoxic agents, the values of surviving fraction have agreed well between the 3 assays. This implies that the post-treatment survival of treated cells is independent of whether they are allowed to grow intramuscularly in the lung, or in suspension in soft agar.
The cells that can be extracted from the B16 melanoma are to some extent heterogeneous. Under the microscope they can be seen to vary in melanin content, and it is also possible to identify cells whose melanin is aggregated into globules, which we presume to be macrophages (Evans, 1972) . WVhen the cells are allowed to grow in the lung, the resulting nodules vary in melanin content, as reported by Hill and Stanley (1975) . Our work with CY has shown that in response to treatment the tumour tissue becomes much blacker. This is due partly to the conservation of melaniin, released from dead cells and taken up by macrophages, but also perhaps to an increase in the melanin content of cells that were producing melanin.
The assays described here allow more reliable estimates to be made of the survival of clonogenic cells than are possible from the analysis of tumour regrowth curves. Griswold (1975) .
